FORGHIERI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.808
EU - Europa 4.164
AS - Asia 3.224
SA - Sud America 411
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
Totale 17.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.710
GB - Regno Unito 1.374
CN - Cina 1.016
SG - Singapore 960
IT - Italia 687
SE - Svezia 595
HK - Hong Kong 532
DE - Germania 388
BR - Brasile 335
FI - Finlandia 245
RU - Federazione Russa 231
VN - Vietnam 201
UA - Ucraina 176
FR - Francia 134
TR - Turchia 125
IN - India 93
KR - Corea 76
BG - Bulgaria 69
ID - Indonesia 56
CA - Canada 51
JP - Giappone 42
BE - Belgio 39
CZ - Repubblica Ceca 37
NL - Olanda 28
ES - Italia 27
AR - Argentina 25
BD - Bangladesh 24
IE - Irlanda 23
LT - Lituania 23
IR - Iran 19
MX - Messico 19
PL - Polonia 19
ZA - Sudafrica 16
AT - Austria 14
BZ - Belize 13
EC - Ecuador 12
EU - Europa 12
CH - Svizzera 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
EG - Egitto 9
MA - Marocco 9
PY - Paraguay 8
SK - Slovacchia (Repubblica Slovacca) 8
UZ - Uzbekistan 8
DK - Danimarca 7
AU - Australia 6
MY - Malesia 6
RO - Romania 6
VE - Venezuela 6
CO - Colombia 5
IL - Israele 5
NO - Norvegia 5
AZ - Azerbaigian 4
JM - Giamaica 4
LB - Libano 4
PA - Panama 4
PE - Perù 4
PK - Pakistan 4
TW - Taiwan 4
UY - Uruguay 4
GR - Grecia 3
JO - Giordania 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
KE - Kenya 2
MK - Macedonia 2
PS - Palestinian Territory 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BH - Bahrain 1
BW - Botswana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MZ - Mozambico 1
NG - Nigeria 1
PH - Filippine 1
SV - El Salvador 1
Totale 17.670
Salva come PNG Salva come JPEG
Città #
Fairfield 1.188
Ashburn 1.014
Southend 978
Santa Clara 837
Woodbridge 746
Singapore 621
Chandler 591
Houston 561
Hong Kong 523
Ann Arbor 455
Seattle 451
Cambridge 357
Wilmington 337
Nyköping 331
Jacksonville 328
Dearborn 317
Hefei 251
Modena 205
London 188
Beijing 182
New York 164
Helsinki 152
Los Angeles 127
Munich 98
Chicago 83
San Diego 80
Fremont 73
Sofia 68
Bremen 67
Princeton 66
Ho Chi Minh City 65
Eugene 63
Izmir 63
Seoul 61
Moscow 56
Shanghai 53
Bologna 52
Council Bluffs 48
Hanoi 48
Buffalo 46
Dallas 43
The Dalles 43
Jakarta 41
Milan 39
San Jose 39
Redwood City 34
Brussels 32
São Paulo 31
Boardman 30
Salt Lake City 28
Turku 28
Columbus 27
Tokyo 27
Brooklyn 25
Atlanta 24
Des Moines 24
Dublin 22
Orem 22
Toronto 19
Chennai 18
Montreal 18
Denver 17
Stockholm 17
Dong Ket 16
Guangzhou 16
Las Vegas 16
Frankfurt am Main 14
Phoenix 14
Rome 14
Albuquerque 13
Belize City 13
Kunming 13
Paris 13
Warsaw 13
Washington 13
Brno 12
Da Nang 12
Boston 11
Rio de Janeiro 11
San Francisco 11
Wuhan 11
Leawood 10
Nanjing 10
Tampa 10
Elk Grove Village 9
Johannesburg 9
Kilburn 9
Lauterbourg 9
Pavia 9
Redondo Beach 9
Chiswick 8
Kent 8
Nantes 8
Norwalk 8
Poplar 8
San Mateo 8
Sterling 8
Vienna 8
Barcelona 7
Mexico City 7
Totale 13.040
Salva come PNG Salva come JPEG
Nome #
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 389
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 365
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 346
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 344
B cells and herpesviruses: a model of lymphoproliferation 341
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 335
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 327
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 325
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 320
Acute appendicitis in adult neutropenic patients with hematologic malignancies 310
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 310
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 308
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 299
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 299
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 299
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 291
Mucorales-specific T cells in patients with hematologic malignancies 287
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 286
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 285
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 283
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 283
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 283
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 281
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 281
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 280
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 278
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 268
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 266
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 260
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 260
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 258
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 258
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 251
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 248
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 244
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 244
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 243
Inflammatory myofibroblastic tumor of the bone marrow. 241
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 240
Pain and emotional distress in leukemia patients at diagnosis. 236
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 235
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 234
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 233
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 231
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 229
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 229
How I treat HHV8/KSHV-related diseases in posttransplant patients. 225
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 225
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 223
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 222
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 222
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 221
Splenomegaly in hematological malignancies and portal hypertension 219
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 216
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 208
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 205
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 202
Philadelphia chromosome-positive acute lymphoblastic leukemia 200
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 196
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 189
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 189
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 186
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 183
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 180
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 170
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 163
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 161
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 133
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 121
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 120
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 111
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 100
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 87
The dynamic functions of IRF4 in B cell malignancies 72
Totale 17.892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.217 0 0 0 0 0 185 141 251 99 261 141 139
2021/20221.553 69 208 160 96 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.191 33 48 92 88 215 139 137 210 23 22 77 107
2024/20253.149 129 44 72 214 567 464 237 175 397 96 284 470
2025/20263.041 480 241 414 572 884 450 0 0 0 0 0 0
Totale 17.892